UN health agency to examine lower-cost ‘ biosimilar ’ drugs to expand access to cancer treatment

As a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries, the World Health Organization (WHO) said today that it will launch a pilot project for prequalifying so-called “ biosimilars, ” or lower cost drugs.
Source: UN News Centre - Health, Poverty, Food Security - Category: Global & Universal Source Type: news